Top Analyst Upgrades and Downgrades: Aurora Cannabis, Biogen, Micron, Nio, Nvidia, Palo Alto, Tandem Diabetes, Tesla and More

Micron Technology Inc. (NASDAQ: MU) was downgraded to Underperform from Buy at Merrill Lynch, which also downgraded Silicon Motion Technology Corp. (NASDAQ: SIMO) to Neutral. The firm noted that the downgrades for global memory and Korean tech stocks were based on weaker short-term and medium-term momentum or earnings misses rather than based on a change about the long-term views due to March sales, seasonality and Covid-19.

Mosaic Co. (NYSE: MOS) was named as the Zacks Bear of the Day stock. The firm said that there may not be a glimmer of hope for fertilizers in 2020. Shares last closed at $19.41 and have a consensus price target of $25.80.

MPLX L.P. (NYSE: MPLX) was downgraded to Neutral from Overweight at JPMorgan.

Nio Ltd. (NYSE: NIO) closed down 4.9% at $3.88 on Monday but was trading up over 30% at $5.10 on Tuesday morning after entering into a framework with a Chinese province about manufacturing. Bernstein raised it to Market Perform from Underperform, and Merrill Lynch reiterated its Neutral rating.

Novartis A.G. (NYSE: NVS) was downgraded to Neutral from Buy at Guggenheim.

Nvidia Corp. (NASDAQ: NVDA) was downgraded to Reduce from Neutral and its target price was lowered to $230 from $235 at Nomura/Instinet. Shares closed down 7% at $273.28 on Monday, with a $301.15 consensus target price.

Palo Alto Networks Inc. (NYSE: PANW) was down 2.3% at $237.33 on Monday but its shares were last seen trading down about 15.5% at $200.60 after its guidance was short of expectations. Mizuho maintained its Buy rating but lowered the price target to $245 from $265. Wedbush Securities maintained its Outperform rating but trimmed its target price to $240 from $275. RBC Capital Markets downgraded it to Sector Perform from Outperform and lowered its target to $235 from $280, and JPMorgan downgraded it to Neutral from Overweight and cut its target from $285 to $235.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) closed up 5.5% at $425.38 on Monday despite the market sell-off. Jefferies upgraded it to Buy from Hold and raised its target price to $490 from $355.

Tandem Diabetes Care Inc. (NASDAQ: TNDM) was reiterated as Outperform and its target price was raised to $91 from $85 (versus an $86.79 close) at Raymond James. It had an $82.23 consensus target price, and its 52-week trading range is 447.36 to $91.65.

Tesla Inc. (NASDAQ: TSLA) was downgraded to Hold from Buy at Jefferies, but the firm did raise its target price to $800 from $600. Tesla closed down almost 7.5% at $833.79 a share on Monday and was indicated up about 2% around $250.00 on Tuesday. Its consensus target price was still down at $499.00 or so due to such a wide range of estimates. Ltd. (NASDAQ: WIX) was started with a Buy rating and a $165 target price (versus a $131.50 close) at Needham. It had a $160.13 consensus target price.

Monday’s top analyst upgrades and downgrades included Agilent Technologies, Antero Midstream, Chewy, Domino’s Pizza, eHealth, First Solar, Kraft Heinz, Newmont, Square, Tilray and Wayfair and many more.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.